News

Big Pharma is able to charge Americans significantly higher prices and pad their profits.” Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.) last month called again on Teva and ...
HUDDINGE, Sweden, April 1, 2021 /PRNewswire/ -- Karo Pharma Aktiebolag ("Karo") today announces that the acquisition of the European OTC brand portfolio from Teva Pharmaceuticals (Teva ...
Amid a national spike in attention-deficit/hyperactivity disorder diagnoses, one of the U.S.’ top providers of a popular ADHD medication has run into supply ...
Eliciting an acceptable offer from Teva has been a particularly protracted battle for the states, tribes and municipalities that brought cases against it. While Purdue Pharma, for example ...
was about creating a sustainable generics powerhouse,” Francis said in an interview with Fierce Pharma on Wednesday. “In no way were we in a sense stepping away from generics.” Teva said the ...
It is changing from a generics market leader into one that is starting to compete directly with Big Pharma. Overall, Teva's price/sales ratio [FWD] is 1.53x. This is not only 58.4% lower relative ...
Teva Pharmaceutical Industries Ltd. said it reached a national settlement agreement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis. The ...
Shares of Teva Pharma marginally down 1% in early morning trading, while Alvotech's saw a 5% increase. Alvotech is in charge of development and manufacturing of Selarsdi, while Teva holds the ...
Teva’s betting big on biosimilars and specialty ... For a company that’s often painted as a problem child in pharma, that’s a pretty decent look. But it’s not all sunshine.
Dec 5 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab said on Thursday it will transfer ownership of its business venture that sold generics in Japan to JKI. Israel-based Teva ...